CITIUS ONCOLOGY, INC. (CTOR)
CIK 1851484 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 93.0M shares as of Aug 13, 2026 (10-Q).⊙
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Warrant | 53.9M | $1.09 | 5y | FV $4.6M |
| May2026 Warrant Inducement Investor | 25.6M | $0.9 | — | — |
| Investors Warrants | 16.5M | not tagged | — | — |
| December2025 Offering Investors2 | 15.7M | $0.9 | — | — |
| Prefunded Warrants | 15.2M | $1.0899 | — | — |
| December2025 Offering Investors | 7.0M | $0.0001 | — | — |
| December2025 Placement Offering Agents | 1.2M | $1.3625 | — | — |
| May2026 Loan Agreement Lenders | 1.1M | $0.9 | — | — |
| Placement Agent Warrants | 894,444 | $1.3625 | — | — |
| May2026 Warrant Placement Offering Agent | 894,444 | $1.125 | — | — |
| December2025 Prior Offering Agents | 660,550 | $1.199 | — | — |
| May2026 Warrant Inducement Transaction | 511,111 | $1.09 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 14, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 53.9M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $1.09 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $6.1M as of Sep 30, 2025.
Rough fully diluted estimate: 146.9M = 93.0M O/S + 53.9M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 14, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 93.0M | Aug 13, 2026 |
| + Warrant (if exercised) | 53.9M | Jun 30, 2026 |
| + May2026 Warrant Inducement Investor (if exercised) | 25.6M | Jun 30, 2026 |
| + Investors Warrants (if exercised) | 16.5M | Jun 30, 2026 |
| + December2025 Offering Investors2 (if exercised) | 15.7M | Jun 30, 2026 |
| + Prefunded Warrants (if exercised) | 15.2M | Dec 10, 2025 |
| + December2025 Offering Investors (if exercised) | 7.0M | Jun 30, 2026 |
| + December2025 Placement Offering Agents (if exercised) | 1.2M | Jun 30, 2026 |
| + May2026 Loan Agreement Lenders (if exercised) | 1.1M | Jun 30, 2026 |
| + Placement Agent Warrants (if exercised) | 894,444 | Jun 30, 2026 |
| + May2026 Warrant Placement Offering Agent (if exercised) | 894,444 | Jun 30, 2026 |
| + December2025 Prior Offering Agents (if exercised) | 660,550 | Jun 30, 2026 |
| + May2026 Warrant Inducement Transaction (if exercised) | 511,111 | Jun 30, 2026 |
| Fully diluted estimate | 232.2M | +149.7% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $280.2Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full CTOR workspace